

![]() |
|||||||||||||
|
| All | Since 2020 | |
| Citation | 6651 | 4087 |
| h-index | 26 | 21 |
| i10-index | 174 | 83 |
Search
News & Updation
REVIEW ON DEPRESSION & NOVEL ANTIDEPRESSANTS IN CLINICAL PRACTICE
Angad Bhatia* and Kuldeep G. Saini
ABSTRACT In terms of prevalence & suffering, morbidity, dysfunction & economic burden Depression is considered as a disorder of major public health importance. It is a common illness which can severely limit psychosocial functioning & QOL. As per the WHO reports of 2008, depression was known to be the third cause of Worldwide disease burden & is projected to be the leading contributor by 2030. It is a as a common and serious medical illness that negatively affects how one feels, thinks, and acts. The classification is based on ICD-10 & DSM-5 criteria. Here we review data on various aspects of Depression, symptomatology, epidemiology, diagnosis & types, treatment alternatives & efficacy and issues of various antidepressants. Keywords: . [Download Article] [Download Certifiate] |
